Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naïve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.
By:
Fred Poordad (University of Texas Health Science Center San Antonio Texas) Imprint: W B Saunders Co Ltd Country of Publication: United Kingdom Volume: 15-3 Dimensions:
Height: 239mm,
Width: 163mm,
Spine: 18mm
Weight: 460g ISBN:9781455711079 ISBN 10: 1455711071 Series:The Clinics: Internal Medicine Publication Date:23 September 2011 Audience:
Professional and scholarly
,
Undergraduate
Format:Hardback Publisher's Status: Active